RT Book, Section
A1 Méndez, Jane E.
A1 Singletary, S. Eva
A1 Babiera, Gildy V.
A2 Kuerer, Henry M.
SR Print(0)
ID 6415594
T1 Chapter 72. Surgery in Patients with Stage IV Metastatic Breast Cancer
T2 Kuerer's Breast Surgical Oncology
YR 2010
FD 2010
PB The McGraw-Hill Companies
PP New York, NY
SN 978-0-07-160178-8
LK accesssurgery.mhmedical.com/content.aspx?aid=6415594
RD 2024/04/24
AB Historically,  women  who  present  with  stage  IV  metastatic  breast  cancer  (MBC),  even  those  with  an  intact  primary  tumor,  are  not  offered  surgical  treatment.  Instead,  the  recommended  primary  treatment  approach  is  systemic  therapy.  However,  improved  breast  cancer  screening  and  imaging  technology  have  presented  a  different  dilemma:  patients  with  MBC  may  have  oligometastatic  or  stable  metastatic  disease  with  an  operable  intact  primary  tumor,  suggesting  that  surgery  may  be  effective.  Furthermore,  over  the  past  25  years,  multimodality  treatments  for  new  and  advanced  breast  cancers  have  resulted  in  improved  median  survival  times  for  patients  with  MBC.1  Therefore,  for  patients  with  MBC,  it  is  time  to  reevaluate  the  role  of  resection  of  the  intact  primary  tumor  and  the  role  of  metastasectomy  in  patients  without  an  intact  primary  tumor.